Format

바카라 영상조작

Choose Destination
강원 랜드 룰렛 후기 1995;13(2):94-7.

카지노사이트솔레어카지노인터넷바카라사이트〖opm65.xyz〗{}╭바카라 룰♨더킹카지노⇔필리핀 카지노 앵벌이↘카지노 앵벌이↛바다이야기 게임

카지노사이트솔레어카지노바다 이야기 무료 다운로드〖opm65.xyz〗{}◑카지노위키☜10000 꽁 머니☂마카오 카지노 대박╍온라인바카라 이기는법↺시카고 슬롯 머신

1
Department of Urology, University of Bochum, Marienhospital, Herne, Germany.

카지노사이트솔레어카지노바카라 무료 머니〖opm65.xyz〗{}▀포커 룰ヘ슬롯 사이트╚바카라 예측 프로그램↟인터넷 게임 추천♨마카오 카지노 호텔

Laser treatment has become increasingly attractive for treatment of bladder-outlet obstruction due to benign prostatic hyperplasia (BPH). However, it is unknown whether laser treatment may be as effective as transurethral resection of the prostate (TURP), how long effective treatments may last, and whether there may be substantial differences with respect to clinical outcome between different laser treatment modalities currently under clinical investigation. TULIP (transurethral ultrasound-guided laser-induced prostatectomy) was one of the very first laser systems designed for treatment of BPH. The procedure is performed exclusively under transurethral ultrasound guidance, with which the surgeon has to become familiar. However, data reported from single-institution as well as multicenter studies demonstrate that the technique has only a small learning curve. The majority of patients treated by TULIP will experience substantial improvements in subjective and/or objective symptoms, which nevertheless do not appear to be as good as those seen after TURP. This is also shown by data from a prospective and randomized TULIP versus TURP study. However, it has to be emphasized that the clinical significance of such differences remains unknown. Advantageous for TULIP (which may be performed under analgosedation) are reduced blood loss, hospitalization, and rate of postoperative sexual dysfunction. Disadvantageous (as compared with TURP) are the delayed onset of success combined with the prolonged catheterization time and irritative symptoms in the early postoperative phase. In addition, as no tissue is obtained for histology examination, incidental prostate cancer may be missed.

PMID:
7542972
[Indexed for MEDLINE]

카지노사이트솔레어카지노사설바둑이게임〖opm65.xyz〗{}囍인터넷바둑이♛카지노 있는 나라╋우리카지노총판문의◦아도 사끼┠마카오 카지노 여자

카지노사이트솔레어카지노홀덤 족보〖opm65.xyz〗{}⇠바카라스토리♩카지노 이벤트╩텍사스 홀덤カ바다 이야기 무료 다운로드☏시카고 카지노

카지노사이트솔레어카지노카지노 슬롯 머신 전략〖opm65.xyz〗{}✈카지노톡┃정선 카지노 게임 종류⇥홀덤 게임➼황금성 게임 다운로드♪ 해적바둑이게임주소

바카라 신규 가입
jnice02-ina17-ad-wb-0280